Potential Roles of miRNAs in Acute Rejection for Vascularized Composite Allotransplantation

Area of Science:

• Transplantation immunology
• Molecular biology
• Regenerative medicine

Background:

• Microsurgery advancements have enabled vascularized composite allotransplantation (VCA).
• Acute rejection and long-term graft survival remain significant challenges in VCA, similar to organ transplantation.
• Understanding the molecular mechanisms of VCA rejection is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the molecular mechanisms underlying acute rejection in VCA.
• To identify potential molecular biomarkers for diagnosing and managing VCA rejection.
• To elucidate the role of microRNAs (miRNAs) in VCA acute rejection.

Main Methods:

• Construction of a rat VCA animal model using Brown Norway and Lewis rats.
• Monitoring of physical changes and collection of specimens during acute immune rejection.
• Utilizing microRNA sequencing, RT-qPCR, and bioinformatics analysis to identify differentially expressed miRNAs.

Main Results:

• Identified specific microRNAs (miRNAs) significantly associated with acute rejection in VCA.
• Found that rno-miR-21-5p, rno-miR-340-5p, rno-miR-1-3p, and rno-miR-195-5p are key players in VCA rejection.
• Demonstrated the role of miRNAs in regulating gene expression at the post-transcriptional level in the context of VCA.

Conclusions:

• A specific miRNA signature shows potential as an auxiliary diagnostic indicator for VCA rejection.
• This miRNA signature could assist clinicians in timely adjustments to immunosuppressive therapy during acute rejection.
• Further research into miRNA biomarkers may improve management strategies for VCA recipients.